Old Web
English
Sign In
Acemap
>
authorDetail
>
Catherine Nalpas
Catherine Nalpas
Janssen Pharmaceutica
Regimen
Immunology
Internal medicine
Simeprevir
Medicine
2
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015
2019
Zeitschrift Fur Gastroenterologie
Christoph Sarrazin
Peter Buggisch
Stefan Mauss
Tobias Müller
Tim Zimmermann
Hartwig Klinker
Anita Pathil-Warth
M. Schlag
Catherine Nalpas
Sven Wegner
I. Lonjon-Domanec
Karl-Georg Simon
Show All
Source
Cite
Save
Citations (2)
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.
2017
PLOS ONE
Tarik Asselah
Christophe Moreno
Christoph Sarrazin
M Gschwantler
Graham R. Foster
Antonio Craxì
Peter Buggisch
Faisal M. Sanai
Ceyhun Bicer
Oliver Lenz
Gino Van Dooren
Catherine Nalpas
I. Lonjon-Domanec
Michael Schlag
M. Buti
Show All
Source
Cite
Save
Citations (6)
1